These results indicate that inhibiting 20-HETE production or blocking its action protects against Ang II-induced cardiac hypertrophy, primarily by suppressing ROS-mediated activation of MAPK/ERK and PI3K/Akt signaling pathways. The gene discussed is AKT1; the disease is cardiac hypertrophy.